Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA-101 pharmacokinetics and safety study in healthy adults, systemic mastocytosis, and allergic asthma
NL-OMON41045Active, not recruiting
- Sponsor
- Patara Pharma
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of RVT-1601 in systemic mastocytosis (SM) and allergic asthma (3 arms), sponsored by Patara Pharma. Primary endpoints: Pharmacokinetics and Relative bioavailability. Started Apr 2014; status: active, not recruiting.
02
Drugs
RVT-1601
03
Conditions
systemic mastocytosis (SM)allergic asthma
Beyond the preview
Go deeper on NL-OMON41045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41045.